Study period | |||||||||
---|---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close-out | ||||||
Timepoint | Before surgery | Before surgery | During surgery | Postoperative day 1 | Postoperative day 3 | Postoperative day 5 | Postoperative day 7 | Postoperative day 30 | Postoperative day 90 |
Enrolment | |||||||||
Informed consent | × | ||||||||
Eligibility screen | × | ||||||||
Allocation | × | ||||||||
Randomization | × | ||||||||
Interventions | |||||||||
Tissue samples collection | × | ||||||||
Ketorolac tromethamine | × | × | × | ||||||
0.9% saline | × | × | × | ||||||
Assessments: | |||||||||
Vital signs | × | × | × | × | × | × | × | × | |
Hematology examination | × | × | × | × | × | × | × | × | |
CTA scan of cervical thoracic and abdominal aorta artery | × | × | × | ||||||
Chest X-ray | × | × | × | × | × | × | |||
Echocardiography | × | × | × | × | |||||
Adverse events | × | × | × | × | × | × | × | × | |
Complications | × | × | × | × | × | × | × | × |